Overview

Effect of Imeglimin on QT/QTc Intervals in Healthy Subjects

Status:
Completed

Trial end date:
2016-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the effect of a single therapeutic dose and a single supra-therapeutic dose of imeglimin on the QT/QTc interval

Phase:

Phase 1

Details

Lead Sponsor:

Poxel SA

Treatments:

Moxifloxacin
Norgestimate, ethinyl estradiol drug combination